From: The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation
 | N | Mean serum level (pg/mg) | Range (pg/ml) | Mean CSF level (pg/ml) | Range (pg/ml) | Ratio | Range |
---|---|---|---|---|---|---|---|
IL-6 | |||||||
 NC | 11 | 2.6 | 0.0–9.4 | 3.2 | 0.5–9.7 | 1.23 | 0.0–26.8 |
 HSVE | 10 | 12.7 | 0.0–57.35 | 315.5 | 1.77–552.9 | 24.84 | 0.0–57.35 |
 C19 total | 18 | 92.5 | 0.75–552.4 | 37.0 | 0.68–552.1 | 0.4 | 0.02–5.09 |
 C19 lowpct | 12 | 51.3 | 0.75–345.5 | 7.00 | 0.68–24.72 | 0.14 | 0.02–5.09 |
 C19 highpct | 6 | 174.9 | 7.1–552.4 | 96.9 | 1.54–552.1 | 0.55 | 0.02–0.98 |
IL-16 | |||||||
 NC | 11 | 206.1 | 165.3–275.8 | 45.2 | 39.3–57.6 | 0.22 | 0.16–0.3 |
 HSVE | 5 | 253.2 | 209.8–316.6 | 115.7 | 73.8–18.8 | 0.46 | 0.31–0.53 |
 C19 total | 18 | 358.9 | 109.7–775.8 | 53.3 | 44.7–74.8 | 0.15 | 0.09–0.52 |
 C19 lowpct | 12 | 295.0 | 109.7–521.2 | 52.4 | 44.7–67.2 | 0.18 | 0.11–0.52 |
 C19 highpct | 6 | 486.8 | 226.2–775.8 | 55.6 | 43.3–74.8 | 0.11 | 0.08–0.19 |
CXCL10 | |||||||
 NC | 11 | 161.6 | 91.37–368.4 | 205.4 | 89.26–416.1 | 1.27 | 0.6–4.04 |
 HSVE | 10 | 256.5 | 83.37–627.5 | 894.8 | 285.9–1087.3 | 3.49 | 1.56–13.04 |
 C19 total | 18 | 405.2 | 32.77–1234.3 | 226.7 | 49.06–622.1 | 0.56 | 0.08–7.71 |
 C19 lowpct | 12 | 301.8 | 32.77–765.7 | 178.0 | 13.91–622.1 | 0.59 | 0.08–7.71 |
 C19 highpct | 6 | 612.1 | 57.92 | 324.0 | 49.83–565.1 | 0.53 | 0.2–0.98 |
PGRN | |||||||
 NC | 22 | N.a | N.a | 0.9963 | 0.49–2.09 | n.a | n.a |
 MHSVE | 6 | N.a | N.a | 5.6717 | 1.04–9.81 | n.a | n.a |
 C19 total | 23 | N.a | N.a | 1.675 | 0.67–3.04 | n.a | n.a |
 C19 lowpct | 13 | N.a | N.a | 1678 | 0.67–3.04 | n.a | n.a |
 C19 highpct | 10 | N.a | N.a | 1.671 | 07.5–2.22 | n.a | n.a |